Business

Also, Neurophet has raised over $20 million for the development and global expansion of its AI-based brain imaging analysis software suite.

Dr. Matt Sakumoto, Nabla's chief clinical product officer, says he wants the next wave of AI tools to empower every member of a clinical team to collect patients' stories and follow them along their care journey.

Despite progress in using advanced analytics, Jill Seys, senior director for North America analytics at HIMSS, says that many healthcare organizations are still challenged with tailoring communications for patients.

The company will use the funds to expand its commercial operations, grow its workforce, and scale its platform and infrastructure.

AI can streamline workflows across health systems, but Greg O'Neill, ChristianaCare's director of patient education, says the technology misses its purpose if the information it provides to patients and families isn't useful.

The acquisition will enable Stryker to expand its portfolio with intravascular lithotripsy technology from Amplitude Vascular Systems for treating severely calcified arteries.

According to Tom Leary, HIMSS Foundation executive director, the foundation assists with costs associated with earning digital healthcare certifications to remove barriers for students from underserved communities.

Kamal Singh, senior vice president at WestBridge Capital, says AI tools from OpenAI and Anthropic will disrupt basic health chatbots but not specialized startups.

The funding brings the company's total raise to $60 million.

University of Iowa Health Care's Josh Wilda says that TEFCA may be useful not only for providers, but to unify fragmented patient portals and give patients a single access point to retrieve their health data across systems.